McMaster University

McMaster University

Stem Cell and Cancer Research Institute (SCC-RI)

McMaster's Stem Cell and Cancer Research Institute (SCC-RI) explores the underlying cellular and molecular origins that initiate human cancer by employing human stem cells as a model system. The Institute's impressive shared facilities are designed to help mitigate the high cost of human stem cell research that has made entry into the field almost prohibitive for investigators in Canada.

On the cutting edge of human stem cell research, our team of scientists integrates expertise in epigenetics, signalling pathways, neural cancer stem cells, human leukemia and pluripotent stem cells. Our ground-breaking research complements the efforts of other stem cell programs and centres in Canada and around the world.

With its particular focus in human stem cell research, the SCC-RI provides interested graduate students and postdoctoral fellows an exciting opportunity to pursue this specialized training in Canada. The Institute will also provide an open forum to educate the public about this important research and work with sectors developing ethical guidelines and policy for therapeutic applications to assure Canadians will receive the best health care possible.

StemCellShorts


Mick Bhatia's research on pluripotent stem cells makes Canadian Cancer Society's Top 10 research stories of 2014

Mick Bhatia

Dr. Mick Bhatia's discovery that the type of cells used to make human induced pluripotent stem cells determines what can be best done with them is being honoured as one of the Canadian Cancer Society's Top 10 research stories of 2014.

The study, published in Nature Communications, showed that human iPSCs have a memory at the genetic level of the cell type used to make them, which increases their ability to differentiate to that tissue type after being reverted to a stem cell state.  For example, Dr. Bhatia was able to show that stem cells made from blood cells are able to make blood ten times better than stem cells created from other parent tissue types. This discovery will be applied to improving stem cell therapy treatments for patients, enhancing disease modeling, and building on successes in the area of personalized drug discovery.

The Canadian Cancer Society's yearly list of Top 10 Research Stories highlights notable research achievements that have been funded, in full or in part, by the Society.

More about Mick Bhatia's discovery Read more about Mick Bhatia's Discovery

McMaster University to play key role in new Ontario Institute for Regenerative Medicine

McMaster University stem cell researcher Mick Bhatia will lead one of three teams in tackling the province's highest-priority diseases, with funding from the new Ontario Institute for Regenerative Medicine (OIRM), the Ontario government announced yesterday.

Press Release:

New Ontario Institute to Tackle Costly Diseases of Aging — OSCI and CCRM to form the Ontario Institute for Regenerative Medicine (Government of Ontario)

More about Mick Bhatia leading regenerative medicine research Go to complete news story

Valid XHTML 1.0 Transitional Level Double-A conformance, W3C WAI Web Content Accessibility Guidelines 2.0